On the afternoon of January 4, 2018, the "High-level Expert Seminar on Shengbai Oral Liquid" was held in Beijing, the capital of China, and more than 40 authoritative oncology experts from more than 20 hospitals, including the Cancer Hospital of the Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, China-Japan Friendship Hospital, Peking University Cancer Hospital, Beijing Tiantan Hospital Affiliated to Capital Medical University, and Beijing Shijitan Hospital Affiliated to Capital Medical University. Professor Sun Yan, academician of the Chinese Academy of Engineering, attended the high-level expert seminar in his busy schedule.

The meeting was presided over by Ms. Zhou Huiying, assistant to the president and deputy general manager of Hubei Mengyang Pharmaceutical Co., Ltd. Professor Sun Yan, academician of the Chinese Academy of Engineering, made an academic report entitled "The Role of Traditional Chinese Medicine in Clinical Oncology" for the conference, in the report, Professor Sun Yan made a detailed elaboration on the progress of China's tumor incidence trend and diagnosis and treatment in the past 60 years, the characteristics and advantages of traditional Chinese medicine in tumor treatment, and the thinking of comprehensive treatment of traditional Chinese and Western medicine for tumors. 30 years of research have found that some Chinese herbal extracts can effectively inhibit PD-L1, inhibit excessive Ts cells, induce the production of interferon, and have a synergistic effect with interleukin 2 to promote the recovery of immune function; 2. The application of the syndrome differentiation and treatment system of traditional Chinese medicine in the treatment of tumors, the use of Fuzheng Peiben traditional Chinese medicine can regulate immune function and enhance the body's anti-tumor ability; The use of blood circulation and blood stasis prescriptions can effectively inhibit new blood vessels, prevent and treat tumors; It is used to strengthen the kidney and spleen, and to protect the bone marrow function by nourishing qi and blood. The Shengbai oral liquid developed by Professor Shao Mengyang is composed of this treatment method, which has a definite effect on leukopenia after bone marrow suppression after tumor radiotherapy and chemotherapy, and is worthy of wide clinical application.

Subsequently, Mr. Wang Yongjun, Medical Marketing Director of Hubei Mengyang Pharmaceutical Co., Ltd., introduced the theoretical basis and characteristics of Shengbai Oral Liquid, and made a detailed report on the clinical research results of Shengbai Oral Liquid in the clinical prevention and treatment of bone marrow suppression caused by tumor radiotherapy and chemotherapy. At the same time, the current situation and future development plan of Mengyang Pharmaceutical Company were reported to the participating experts, and a detailed report was made on the entry of Shengbai Oral Liquid into the new national medical insurance catalog, its inclusion in the list of drugs for the treatment of tumor clinical pathways, the development of national multi-center clinical studies, and the registration of natural medicines in Canada.

Then, Professor Feng Xingzhong of Beijing Shijitan Hospital affiliated to Capital Medical University shared typical cases of clinical application of Shengbai Oral Liquid, and introduced the white blood cell count and clinical symptom improvement before and after medication, so that the participating experts could see the exact efficacy of Shengbai Oral Liquid, and there were quantitative indicators to evaluate the efficacy, so that everyone could see it at a glance; Professor Feng Xingzhong also emphasized that the treatment of tumors should be based on the holistic concept of traditional Chinese medicine and syndrome differentiation and treatment, which can better reflect the clinical value of drugs.

When the meeting entered a heated discussion session, the experts highly affirmed and recognized the efficacy of Shengbai oral liquid, and put forward some good suggestions in clinical promotion. Finally, Professor Sun Yan concluded his speech: the motherland's traditional Chinese medicine is broad and profound, and has protected the health of the people for thousands of years, and I hope that everyone will seize the great opportunity for the country to vigorously develop traditional Chinese medicine, work hard, study hard, and develop good products like Shengbai oral liquid, so as to better relieve the pain of patients, and I believe that with the joint efforts of everyone, traditional Chinese medicine will shine in the field of tumor treatment in the future!